|
|
|
Company
|
|
Sangamo BioSciences, Inc. |
|
Sangamo BioSciences, Inc. (Nasdaq: SGMO) is a biotechnology company focused on the research and development of novel transcription factors for regulating human, plant and microbial genes. The company has developed a unique and proprietary method of controlling gene expression (turning genes "on" or "off") by the engineering of a specific class of transcription factors known as zinc finger DNA binding proteins, or ZFPs. Sangamo scientists can generate novel ZFPs capable of recognizing any gene whose sequence is known, resulting in the ability to turn "on" and turn "off" target genes of medical and commercial interest. The company intends to establish this capability, known as Universal Gene RecognitionT, as a widely used technology for commercial applications in pharmaceutical drug discovery, human therapeutics, clinical diagnostics, and agricultural and industrial biotechnology.
| Market Assistant |
 |
PrecisionAlert |
|
This company has no data
|
|
|
|
|
|
|
_web.gif)
